Overview of Envita's Comprehensive Smart Oncology® Program

Almost 600,000 Americans died of cancer in 2007. In a country where 1.5 million new cases of cancer are reported each year, the importance of discovering new and better ways of attacking the disease is vital. But despite the billions of dollars that have been spent on cancer research, cancer treatments today are relatively stagnant and standardized.

Envita is one of only a handful of clinics around the world that is moving beyond the limitations of standardized treatments and is thinking outside the box.

Leading the Way in Natural Medicine

The only clinic of its kind, Envita offers an extensive array of advanced natural treatments from all over the world under one roof.  Envita is one of the leading natural medical clinics in the United States and abroad, advancing the field by providing state-of-the-art research and sophisticated, one-of-a-kind treatment options.

All of Envita’s treatments are research-supported and based upon reports in the published scientific literature.  Our treatments are reviewed by an Institutional Review Board (IRB) to ensure patient safety in accordance with the standards of the Food and Drug Administration (FDA).

On April 15, 2008, Envita revolutionized the field of natural medicine by submitting an investigative new drug (IND) application to the Food and Drug Administration (FDA) for a Phase I clinical drug trial for the treatment of cancer.  It is unprecedented for a natural medical clinic to conduct a Phase I clinical drug trial of this sort.

Envita is committed to research and innovation.  We hope that our clinical trial will be another way for us to change the face of cancer treatment for the better.

The Envita Advantage

Envita’s Comprehensive Smart Oncology® program provides a cutting-edge approach to cancer treatment by bridging the best of what’s available in both the oncological and natural fields. In addition to our aggressive and advanced natural therapies, we have partnered with hematological and radiation oncologists to provide complete and revolutionary oncology care.

Our focus on cancer cell biology and function, as well as on immunotherapy, distinguishes us from other clinics and has led to our progress in innovative and sophisticated therapies. Unlike many conventional methods of treatment, Envita’s Comprehensive Smart Oncology® treatments selectively target cancer cells while minimizing collateral damage to healthy cells. The overlapping mechanisms of our treatments make for a complete, effective, and smart cancer care program.

Our goal is to improve overall outcomes and raise the quality of life for our patients, which are the true benchmarks of successful treatment. In so doing, we are setting a new standard in cancer care.

Immune Function

While conventional use of chemotherapy drugs destroy and disable the immune system, Envita’s innovative therapies can boost immune function and promote the body’s own ability to fight cancer. This difference is critical, as the immune system is the first and last defense against cancer.

Ultimately, no matter what treatment methods are used, it is the immune system that rids the body of cancer and helps speed healing. Our experience has shown that truly effective cancer care must go beyond shrinking tumors to include this element of care.

That is why Envita’s customized treatment plans include a focus on immunotherapy. The American Cancer Society defines immunotherapy as "based on the body's natural defense system, which protects us against a variety of diseases. . . . [and] also works to aid our recovery from many illnesses." Oncologist Herman Kattlove, a medical editor and writer for the American Cancer Society, has recognized that, "Immunotherapy may be one of the only ways left to deal with cancer."*

But restoring the immune system involves much more than juicing, diet, and vitamins. Envita's advanced, research-supported therapies can help modulate and boost immune function for cancer patients.

*"Researchers Test New Weapon in the Ongoing Cancer Fight," The Wall Street Journal, May 23, 2003.

Envita’s Use of Chemotherapy and Radiation

Not all chemotherapy and radiation treatments are equal. Most standard treatments use delivery methods that cause toxicity and collateral damage throughout the whole body. We work with oncologists who use state-of-the-art technology to achieve targeted and manageable administration of chemotherapy and more precise delivery of radiation. Precision in administration and delivery helps to minimize collateral damage to healthy cells and reduce the side effects normally associated with these treatments. When used in combination with our natural therapies, these treatments have been shown to improve clinical outcomes and quality of life for our patients, by selectively targeting cancer cells while simultaneously supporting immune function.

Using Our Treatments in Combination with Conventional Chemotherapy or Radiation

For those patients who are currently using conventional chemotherapy or radiation, or have completed such treatments, our therapies can reduce the devastating side effects of these treatments while helping them to work more efficiently and effectively.

Our Comprehensive Smart Oncology® program includes extensive supportive care options, including adult stem cell treatments to restore immune function and treatments to improve the overall quality of life for cancer patients.

Because our Comprehensive Smart Oncology® treatments are based on cancer cell biology and function, they also have been shown to be effective in patients who have exhibited multi-drug resistance to conventional treatments.

Education

The unknown is scary. Oftentimes, cancer patients live in fear because there is so much that is unexplained to them. But understanding your disease and the treatments you are receiving can go along way toward dispelling fear.

At Envita, we are committed to educating our patients about their disease, so they understand the enemy they are fighting. We also strive to keep our patients informed and involved in their treatment process.

Envita’s Proactive Approach to Remission

The conventional model of cancer treatment operates on a “wait and see” basis. After treatment is administered, patients wait to see how, or even if, their bodies respond to treatment and how long the effects will last. Oncologists use the term “remission” and not “cure,” because it is unknown whether the cancer will come back later on. There still may be cancer cells left in the body, even though there is no sign of it at the time. These cancer cells, which can break out of dormancy, often account for the recurrence of disease.

At Envita, we take a proactive approach to remission by providing our patients with long-term treatment plans. The battle with cancer does not end with the disappearance of a tumor. We continue to provide immune support and other treatments for our cancer patients long after they are done with chemotherapy and radiation regimens. Our long-term approach to care ensures that patients are able to take control over their remission process instead of waiting in fear that their cancer will return.

Revolutionizing Cancer Care

There is so much fear surrounding cancer diagnoses is because of the poor results of standardized treatment plans, which can produce horrible side effects, recurrence of disease, and in the worst cases, lost lives.

But revolutionizing patient care and outcomes has been Envita’s goal for almost a decade. The future of cancer therapy is bright, and making it a manageable disease is the Envita goal.

To obtain a "Research Login" and view Envita's Treatment  options and therapies please contact us at 866-830-4576.